Michele Ollier serves as Executive at Aegerion Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Michele Ollier has executed 13 insider transactions totaling $37.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 12, 2016 involved exercising options for 202,634 shares valued at $1.2M.
Michele Ollier currently holds 4,690,906 shares of Aegerion Pharmaceuticals, Inc. (AEGR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michele Ollier has been a net seller of AEGR stock. They have purchased $13.7M and sold $23.4M worth of shares.
Michele Ollier's most recent insider trade was on Dec 12, 2016, when they sold 202,634 shares at $5.77 per share.
Get notified when new Form 4 filings are submitted
| $10.00 |
| Discretionary |
| Mar 18, 2015 | NERV | $974.7K | Purchase | 202,634 | $4.81 | Discretionary |
| Jul 7, 2014 | NERV | $7.7M | Purchase | 1,287,500 | $6.00 | Discretionary |
| Jul 7, 2014 | NERV | $2.0M | Purchase | 333,333 | $6.00 | Discretionary |
| Jul 7, 2014 | NERV | $684.5K | Conversion | 114,077 | $6.00 | Discretionary |
| Jul 7, 2014 | NERV | $371.5K | Conversion | 61,922 | $6.00 | Discretionary |
| Jul 29, 2011 | AEGR | $537.5K | Sale | 36,788 | $14.61 | Discretionary |
| Jun 29, 2011 | AEGR | $12.8M | Sale | 877,723 | $14.61 | Discretionary |
| Oct 27, 2010 | AEGR | $6.7M | Conversion | 881,128 | $7.60 | Discretionary |
| Oct 27, 2010 | AEGR | $0 | Conversion | 1,367,346 | $N/A | Discretionary |
| Oct 27, 2010 | AEGR | $3.0M | Purchase | 315,789 | $9.50 | Discretionary |
| Oct 27, 2010 | AEGR | $0 | Conversion | 477,723 | $N/A | Discretionary |